CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Additional Other Comprehensive Income (Loss)	Equity of Non-controlling Interest	Total
Stockholders' equity, Beginning balance at Feb. 01, 2020	$ 82	$ 452,833	$ (434,221)			$ 18,694
Common Stock, Shares, Outstanding period beginning at Feb. 01, 2020	8,208,227
Net loss			(6,828)			(6,828)
Common stock issuances pursuant to equity compensation awards	$ 1	(3)				(2)
Common stock issuances pursuant to equity compensation awards (in shares)	32,652
Share-based payment compensation		615				615
Common stock and warrant issuance	$ 7	1,418				1,425
Common stock and warrant issuance (in shares)	731,937
Stockholders' equity, ending balance at May. 02, 2020	$ 90	454,863	(441,049)			13,904
Common Stock, Shares, Outstanding period end at May. 02, 2020	8,972,816
Net loss			1,054			1,054
Common stock issuances pursuant to equity compensation awards	$ 1	(6)				(5)
Common stock issuances pursuant to equity compensation awards (in shares)	64,456
Share-based payment compensation		108				108
Common stock and warrant issuance	$ 10	2,375				2,385
Common stock and warrant issuance (in shares)	1,104,377
Stockholders' equity, ending balance at Aug. 01, 2020	$ 101	457,340	(439,995)			17,446
Common Stock, Shares, Outstanding period end at Aug. 01, 2020	10,141,649
Net loss			(4,748)			(4,748)
Common stock issuances pursuant to equity compensation awards		(1)				$ (1)
Common stock issuances pursuant to equity compensation awards (in shares)	313
Exercise of warrants	$ 1	(1)
Exercise of warrants (in shares)	114,698					114,698
Share-based payment compensation		504				$ 504
Common stock and warrant issuance	$ 28	15,805				15,833
Common stock and warrant issuance (in shares)	2,760,000
Stockholders' equity, ending balance at Oct. 31, 2020	$ 130	473,647	(444,743)			29,034
Common Stock, Shares, Outstanding period end at Oct. 31, 2020	13,016,660
Stockholders' equity, Beginning balance at Jan. 30, 2021	$ 130	474,375	(447,455)			$ 27,050
Common Stock, Shares, Outstanding period beginning at Jan. 30, 2021	13,019,061					13,019,061
Net loss			(3,228)		$ (150)	$ (3,378)
Common stock issuances pursuant to equity compensation awards	$ 1	(262)				(261)
Common stock issuances pursuant to equity compensation awards (in shares)	76,341
Share-based payment compensation		668				668
Common stock and warrant issuance	$ 33	21,191				21,224
Common stock and warrant issuance (in shares)	3,289,000
Investment of non-controlling interest					3,430	3,430
Stockholders' equity, ending balance at May. 01, 2021	$ 164	495,972	(450,683)		3,280	48,733
Common Stock, Shares, Outstanding period end at May. 01, 2021	16,384,402
Stockholders' equity, Beginning balance at Jan. 30, 2021	$ 130	474,375	(447,455)			$ 27,050
Common Stock, Shares, Outstanding period beginning at Jan. 30, 2021	13,019,061					13,019,061
Stockholders' equity, ending balance at Oct. 30, 2021	$ 213	537,987	(464,424)	$ (371)	3,148	$ 76,553
Common Stock, Shares, Outstanding period end at Oct. 30, 2021	21,560,514					21,560,514
Stockholders' equity, Beginning balance at May. 01, 2021	$ 164	495,972	(450,683)		3,280	$ 48,733
Common Stock, Shares, Outstanding period beginning at May. 01, 2021	16,384,402
Net loss			(4,249)		(132)	(4,381)
Common stock issuances pursuant to equity compensation awards (in shares)	39,094
Share-based payment compensation		768				768
Common stock and warrant issuance	$ 48	40,095				40,143
Common stock and warrant issuance (in shares)	4,830,918
Stockholders' equity, ending balance at Jul. 31, 2021	$ 212	536,835	(454,932)		3,148	85,263
Common Stock, Shares, Outstanding period end at Jul. 31, 2021	21,254,414
Net loss			(9,492)			(9,492)
Common stock issuances pursuant to equity compensation awards	$ 1	67				68
Common stock issuances pursuant to equity compensation awards (in shares)	306,100
Share-based payment compensation		949				949
Common stock and warrant issuance		136				136
Other Comprehensive Income (loss)				(371)		(371)
Stockholders' equity, ending balance at Oct. 30, 2021	$ 213	$ 537,987	$ (464,424)	$ (371)	$ 3,148	$ 76,553
Common Stock, Shares, Outstanding period end at Oct. 30, 2021	21,560,514					21,560,514